<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Trade Brains Features</provider_name><provider_url>https://tradebrains.in/features</provider_url><author_name>PTI News</author_name><author_url>https://tradebrains.in/features/author/ptinews/</author_url><title>Ajanta Pharma Q2 Results: Consolidated net profit dips 20% to Rs 156.6 cr</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="Vs3VFYGSpl"&gt;&lt;a href="https://tradebrains.in/features/biz-results-ajanta-pharma-3/"&gt;Ajanta Pharma Q2 Results: Consolidated net profit dips 20% to Rs 156.6 cr&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://tradebrains.in/features/biz-results-ajanta-pharma-3/embed/#?secret=Vs3VFYGSpl" width="600" height="338" title="&#x201C;Ajanta Pharma Q2 Results: Consolidated net profit dips 20% to Rs 156.6 cr&#x201D; &#x2014; Trade Brains Features" data-secret="Vs3VFYGSpl" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]&gt; */
&lt;/script&gt;
</html><description>Ajanta Pharma on Thursday reported a 20 per cent decline in consolidated net profit at Rs 156.6 crore in the second quarter ended September 30, impacted by higher expenses and lower sales in the US generics market. The company had posted a consolidated net profit of Rs 195.94 crore in the same period last fiscal, [&hellip;]</description><thumbnail_url>https://tradebrains.in/features/wp-content/uploads/2021/12/Ajanta-Pharma-Cover-image.jpg</thumbnail_url><thumbnail_width>1920</thumbnail_width><thumbnail_height>1280</thumbnail_height></oembed>
